Literature DB >> 17606535

Trends in hospitalizations of HIV-infected children and adolescents in the United States: analysis of data from the 1994-2003 Nationwide Inpatient Sample.

Athena P Kourtis1, Pooja Bansil, Samuel F Posner, Christopher Johnson, Denise J Jamieson.   

Abstract

OBJECTIVE: The objective of this study was to describe trends in hospital use by HIV-infected children and adolescents in the United States in the 10 years from 1994 (before highly active antiretroviral therapy) to 2003 (widespread use of highly active antiretroviral therapy).
METHODS: Data from the Nationwide Inpatient Sample database were used. The most frequent diagnoses were evaluated by year, and trends in hospitalizations for selected diagnoses and procedures were examined by multivariate logistic regression.
RESULTS: In 2003, there were an estimated 3419 hospitalizations of HIV-infected children who were 18 years or younger, compared with 11785 such hospitalizations in 1994 (a 71% decrease). This decrease was more marked among infants and children who were younger than 5 years (94% for boys and 92% for girls) than among adolescents (decrease of 47% for boys and increase of 23% for girls 15-18 years of age). The inpatient fatality rate among HIV-infected children decreased from 5.0% in 1994 to 1.8% in 2003. The number of hospitalizations among HIV-infected children in the highly active antiretroviral therapy era decreased significantly compared with before highly active antiretroviral therapy (1994-1996) for Pneumocystis jiroveci, bacterial infection, or sepsis; fungal infection; encephalopathy; failure to thrive; and lymphocytic interstitial pneumonia. No significant change in the number of hospitalizations for Pneumococcus or cytomegalovirus was observed.
CONCLUSIONS: Dramatic decreases in the number of hospitalizations among HIV-infected children occurred since the advent of highly active antiretroviral therapy in the United States. However, this trend is not seen in hospitalizations of adolescents, particularly girls. Hospitalizations for several HIV-related conditions are less frequent in the highly active antiretroviral therapy era, but for certain other conditions, the hospitalization burden remains high.

Entities:  

Mesh:

Year:  2007        PMID: 17606535     DOI: 10.1542/peds.2006-3268

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  18 in total

Review 1.  Epidemiology, etiology, pathogenesis, and diagnosis of recurrent bacterial meningitis.

Authors:  Marc Tebruegge; Nigel Curtis
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

2.  Executive summary: 2013 update of the guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman
Journal:  Pediatr Infect Dis J       Date:  2013-12       Impact factor: 2.129

3.  Trends in incidence and outcomes of gastroschisis in the United States: analysis of the national inpatient sample 2010-2014.

Authors:  Parth Bhatt; Anusha Lekshminarayanan; Keyur Donda; Fredrick Dapaah-Siakwan; Badal Thakkar; Sumesh Parat; Shilpi Chabra; Zeenia Billimoria
Journal:  Pediatr Surg Int       Date:  2018-07-28       Impact factor: 1.827

4.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

5.  The effect of prophylaxis on pediatric HIV costs.

Authors:  Leslie S Wilson; Lori Hensic; Carly J Paoli; Rituparna Basu; Maria Christenson; Judith T Moskowitz; Diane Wara
Journal:  AIDS Care       Date:  2011-07-25

6.  Disease- and Treatment-related Morbidity in Adolescents With Perinatal HIV Infection in Asia.

Authors:  Adam W Bartlett; Thahira Jamal Mohamed; Tavitiya Sudjaritruk; Nia Kurniati; Revathy Nallusamy; Rawiwan Hansudewechakul; Penh Sun Ly; Khanh Huu Truong; Pagakrong Lumbiganon; Thanyawee Puthanakit; Kulkanya Chokephaibulkit; Lam Van Nguyen; Viet Chau Do; Nagalingeswaran Kumarasamy; Nik Khairulddin Nik Yusoff; Moy Siew Fong; Dewi Kumara Wati; Annette H Sohn; Azar Kariminia
Journal:  Pediatr Infect Dis J       Date:  2019-03       Impact factor: 2.129

7.  Continuous improvement in the immune system of HIV-infected children on prolonged antiretroviral therapy.

Authors:  Adriana Weinberg; Ruth Dickover; Paula Britto; Chengcheng Hu; Julie Patterson-Bartlett; Joyce Kraimer; Howard Gutzman; William T Shearer; Mobeen Rathore; Ross McKinney
Journal:  AIDS       Date:  2008-11-12       Impact factor: 4.177

Review 8.  Adolescents and HIV: prevention and clinical care.

Authors:  Hans M L Spiegel; Donna C Futterman
Journal:  Curr HIV/AIDS Rep       Date:  2009-05       Impact factor: 5.071

9.  Changes in the clinical epidemiology of HIV infection in the United States: implications for the clinician.

Authors:  Kate Buchacz; Maria Rangel; Rachel Blacher; John T Brooks
Journal:  Curr Infect Dis Rep       Date:  2009-01       Impact factor: 3.725

10.  Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-experienced HIV-1 Infected Adolescents: Forty-eight-week Results from IMPAACT P1093.

Authors:  Rolando M Viani; Carmelita Alvero; Terry Fenton; Edward P Acosta; Rohan Hazra; Ellen Townley; Debra Steimers; Sherene Min; Andrew Wiznia
Journal:  Pediatr Infect Dis J       Date:  2015-11       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.